Ligand validation:9NCA

E64: N-[N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO-BUTYL]-GUANIDINE

E64 is a Ligand Of Interest in 9NCA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9NCA_E64_A_301	7%	62%	0.225	0.677	0.59	0.85	-	1	3	0	100%	0.52
9NB2_E64_A_301	39%	65%	0.138	0.843	0.57	0.76	-	-	0	0	100%	0.82
9NBP_E64_A_301	30%	64%	0.16	0.821	0.66	0.73	-	-	0	0	100%	0.75
9NAR_E64_A_301	23%	62%	0.155	0.775	0.62	0.83	-	-	0	0	100%	0.77
9NBF_E64_A_301	22%	64%	0.197	0.811	0.48	0.9	-	1	0	0	100%	0.6
9NC1_E64_A_301	18%	66%	0.168	0.752	0.57	0.73	-	-	0	0	100%	0.76
3IOQ_E64_A_301	86%	48%	0.086	0.954	0.59	1.38	-	4	4	0	100%	1
4D8E_E64_A_501	84%	14%	0.093	0.956	2.24	1.66	6	5	0	0	100%	1
1CV8_E64_A_176	78%	5%	0.105	0.948	2.39	2.96	7	15	0	0	100%	1
8JCR_E64_A_402	76%	21%	0.115	0.95	2.14	1.21	6	3	1	0	100%	1
6YCC_E64_B_301	75%	26%	0.097	0.931	2.04	1	3	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.